Livforsakringsbolaget Skandia’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.09M Hold
17,294
0.08% 131
2025
Q4
$1.83M Sell
17,294
-1,483
-8% -$139K 0.07% 141
2025
Q3
$1.59M Sell
18,777
-900
-5% -$74.1K 0.06% 159
2025
Q2
$1.57M Hold
19,677
0.07% 161
2025
Q1
$1.78M Sell
19,677
-15,120
-43% -$1.41M 0.1% 142
2024
Q4
$3.49M Sell
34,797
-132,300
-79% -$13.6M 0.18% 103
2024
Q3
$19.1M Buy
167,097
+42,990
+35% +$5.11M 1.02% 15
2024
Q2
$15.4M Buy
124,107
+700
+0.6% +$90.2K 1.26% 11
2024
Q1
$16.4M Buy
123,407
+1,000
+0.8% +$123K 1.38% 9
2023
Q4
$13.4M Buy
122,407
+2,544
+2% +$264K 1.28% 12
2023
Q3
$12.4M Sell
119,863
-5,500
-4% -$593K 1.36% 11
2023
Q2
$14.5M Sell
125,363
-12,500
-9% -$1.42M 1.51% 8
2023
Q1
$14.7M Hold
137,863
1.55% 9
2022
Q4
$15.4M Hold
137,863
1.77% 7
2022
Q3
$11.9M Sell
137,863
-32,900
-19% -$2.94M 1.47% 9
2022
Q2
$15.6M Sell
170,763
-8,100
-5% -$718K 1.36% 11
2022
Q1
$14.7M Buy
178,863
+1,400
+0.8% +$110K 0.98% 17
2021
Q4
$13.6M Buy
177,463
+15,800
+10% +$1.26M 0.86% 22
2021
Q3
$12.1M Sell
161,663
-7,100
-4% -$540K 0.76% 26
2021
Q2
$13.1M Buy
168,763
+6,152
+4% +$458K 0.78% 26
2021
Q1
$12M Buy
162,611
+19,388
+14% +$1.43M 0.83% 21
2020
Q4
$11.2M Buy
143,223
+11,947
+9% +$914K 0.95% 17
2020
Q3
$10.4M Buy
131,276
+755
+0.6% +$59.1K 1.11% 16
2020
Q2
$9.63M Buy
130,521
+20,122
+18% +$1.51M 1.1% 14
2020
Q1
$8.11M Buy
110,399
+16,244
+17% +$1.28M 1.14% 15
2019
Q4
$8.17M Buy
94,155
+40,138
+74% +$3.3M 0.97% 18
2019
Q3
$4.34M Hold
54,017
0.51% 42
2019
Q2
$4.32M Buy
54,017
+5,345
+11% +$409K 0.53% 43
2019
Q1
$3.86M Buy
48,672
+1,362
+3% +$102K 0.51% 51
2018
Q4
$3.45M Hold
47,310
0.52% 50
2018
Q3
$3.2M Sell
47,310
-29,239
-38% -$1.86M 0.38% 73
2018
Q2
$4.43M Buy
76,549
+6,498
+9% +$367K 0.4% 64
2018
Q1
$3.64M Hold
70,051
0.35% 76
2017
Q4
$3.76M Sell
70,051
-13,520
-16% -$750K 0.36% 77
2017
Q3
$5.11M Hold
83,571
0.46% 51
2017
Q2
$5.11M Hold
83,571
0.47% 53
2017
Q1
$5.07M Sell
83,571
-110,564
-57% -$6.71M 0.47% 52
2016
Q4
$10.9K Buy
194,135
+67,850
+54% +$3.97M 0.55% 37
2016
Q3
$3.09M Sell
126,285
-170,554
-57% -$9.97M 0.15% 180
2016
Q2
$16.3M Buy
296,839
+18,445
+7% +$982K 0.72% 31
2016
Q1
$14.1M Hold
278,394
0.66% 35
2015
Q4
$14M Sell
278,394
-52,295
-16% -$2.64M 0.66% 34
2015
Q3
$15.6M Hold
330,689
0.82% 23
2015
Q2
$18M Hold
330,689
0.88% 18
2015
Q1
$18.1M Sell
330,689
-19,388
-6% -$1.1M 0.89% 15
2014
Q4
$19M Sell
350,077
-106,477
-23% -$5.93M 0.89% 16
2014
Q3
$25.8M Sell
456,554
-34,898
-7% -$1.96M 0.97% 15
2014
Q2
$27.1M Sell
491,452
-2,139
-0.4% -$117K 0.98% 15
2014
Q1
$26.7M Buy
493,591
+445,340
+923% +$23.1M 1% 15
2013
Q4
$2.3M Sell
48,251
-4,716
-9% -$216K 1.49% 16
2013
Q3
$2.41M Hold
52,967
1.66% 13
2013
Q2
$2.35M Buy
+52,967
New +$2.37M 1.69% 11

Other funds holding MRK

Livforsakringsbolaget Skandia's MRK Position: Q1 2026 in Review

Livforsakringsbolaget Skandia held its Merck (MRK) position steady in Q1 2026 at 17,294 shares worth $2.09M. The position accounts for 0.08% of the portfolio, ranked #131.

Livforsakringsbolaget Skandia first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $27.1M in Q2 2014. 3,791 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Livforsakringsbolaget Skandia held 17,294 shares of Merck worth $2.09M as of Q1 2026.
  • Livforsakringsbolaget Skandia left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.08% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #131 holding.
  • Livforsakringsbolaget Skandia first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Livforsakringsbolaget Skandia's Merck position peaked at $27.1M in Q2 2014.
  • 3,791 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.